Jul. 13 at 4:48 PM
$NUVL Equity Corporate Actions Alert #2026 - 493
Information Regarding the Merger of Nuvalent, Inc. (NUVL)
https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-493
The tender offer by GSK Plc (GSK-NYSE) to acquire all of the outstanding Class A Common Stock of Nuvalent, Inc. (NUVL) is scheduled to expire one minute after 11:59 p.m. ET, on July 14, 2026, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on July 15, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on July 14, 2026. If the merger closes as planned, the stock will remain halted on the day of closing (July 15th) and will be suspended effective July 16, 2026.
At closing, NUVL shareholders will receive
$124.00 for each share held.
